Pfizer scraps daily weight loss pill danuglipron after a liver injury

Science

Pfizer Scraps Daily Weight Loss Pill Danuglipron After A Liver Injury

By CNBC

Pfizer on Monday said it would end development of its experimental daily weight loss pill after a patient experienced a liver injury that was potentially caused by the drug in a trial. The patient did not experience any liver-related symptoms or side ...Read more